AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
Fact-checking journalism is the heart of PolitiFact. Our core principles are independence, transparency, fairness, thorough reporting and clear writing. The reason we publish is to give citizens the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results